Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – An editorial authored by Andrew Fish, Chief Strategy Officer for The Advanced Medical Technology Association (AdvaMed®), appeared this week in Real Clear Health on the benefits of telehealth in connecting patients and health care providers, particularly during the current coronavirus (COVID-19)…
WASHINGTON, D.C. – President and CEO of AdvaMed® Scott Whitaker released the following statement: “Given recent allegations of price gouging in some parts of the country, it is important to be…
WASHINGTON, D.C. – The Advanced Medical Technology Association® announced today that its member respiratory device companies have dramatically expanded the limits of their present production capacity in responding to the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statements by Scott Whitaker, AdvaMed® president and CEO, and Susan Van Meter, executive director of AdvaMedDx®, regarding the medtech…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today sent a letter to the Federal Emergency Management Agency (FEMA) and the administration calling for centralization of procurement and allocation decision-making for medical ventilators…
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19).
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – FDA Commissioner Dr. Stephen Hahn joined a special meeting of AdvaMed®’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work…